Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Flufenamic acid-d4

Flufenamic acid-d4 is deuterium labeled Flufenamic acid. Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca2+ channels, modulating non-selective cation channels (NSC), activating K+ channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.

Product Specifications

CAS Number

1185071-99-1

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

AMPK; Calcium Channel; Chloride Channel; COX; Isotope-Labeled Compounds; Parasite; Potassium Channel

Type

Isotope-Labeled Compounds

Related Pathways

Anti-infection; Epigenetics; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling; Others; PI3K/Akt/mTOR

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Solubility

10 mM in DMSO

Smiles

OC(C(C([2H])=C([2H])C([2H])=C1[2H])=C1NC2=CC(C(F)(F)F)=CC=C2)=O

Molecular Formula

C14H6D4F3NO2

Molecular Weight

285.25

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Guinamard R, et al. Flufenamic acid as an ion channel modulator. Pharmacol Ther. 2013 May;138 (2) :272-84.|[3]Pobbati AV, et al. Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy. Structure. 2015;23 (11) :2076-2086.|[4]Pongkorpsakol P, et al. Cellular mechanisms underlying the inhibitory effect of flufenamic acid on chloride secretion in human intestinal epithelial cells. J Pharmacol Sci. 2017 Jun;134 (2) :93-100.|[5]Pongkorpsakol P, et al. Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation. Eur J Pharmacol. 2017 Mar 5;798:94-104.

Shipping Conditions

Room temperature

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Rabbit Anti-Granzyme M/GZMM Polyclonal Antibody
PAV7741 100 μL

Rabbit Anti-Granzyme M/GZMM Polyclonal Antibody

Sign In for Pricing
View Details
Alpha Synuclein Recombinant Rabbit mAb, Cy3 conjugated
orb2348861 100 µL

Alpha Synuclein Recombinant Rabbit mAb, Cy3 conjugated

Sign In for Pricing
View Details
Human Putative T-complex protein 1 subunit theta-like 1, CCT8L1 ELISA Kit
MBS1606903-01 48 Well

Human Putative T-complex protein 1 subunit theta-like 1, CCT8L1 ELISA Kit

Sign In for Pricing
View Details
Human Putative T-complex protein 1 subunit theta-like 1, CCT8L1 ELISA Kit
MBS1606903-02 96 Well

Human Putative T-complex protein 1 subunit theta-like 1, CCT8L1 ELISA Kit

Sign In for Pricing
View Details
Human Putative T-complex protein 1 subunit theta-like 1, CCT8L1 ELISA Kit
MBS1606903-03 5x 96 Well

Human Putative T-complex protein 1 subunit theta-like 1, CCT8L1 ELISA Kit

Sign In for Pricing
View Details
Human Putative T-complex protein 1 subunit theta-like 1, CCT8L1 ELISA Kit
MBS1606903-04 10x 96 Well

Human Putative T-complex protein 1 subunit theta-like 1, CCT8L1 ELISA Kit

Sign In for Pricing
View Details